ANSUN BIOPHARMA, INC. — Form D/A

ANSUN BIOPHARMA, INC. of SAN DIEGO, CA, a company, filed a Form D amendment with the SEC on 2020-11-24. The offering totals $100.0M, of which $100.0M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2020-11-24
• Form: D/A
• Accession: 0001534671-20-000002
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $100.0M
• Amount sold: $100.0M
• Investors: 19
• Date of first sale: 2019-07-17
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-348287

Issuer

• Name: ANSUN BIOPHARMA, INC.
• CIK: 0001534671
• Entity type: Corporation
• Jurisdiction: CALIFORNIA
• Address: 3030 CALLAN ROAD, SUITE 200, SAN DIEGO, CA, 92121
• Phone: 8584522631

Officers, directors & promoters (18)

Other filings by this issuer (7)

More

• CIK 1534671 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search